HERIBERTO PINA-ANAYA: Open Payments
NPI 1922749217 · ODESSA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,465 in 53 payments from 18 companies in 2025. Trend: 2023 $795 · 2024 $1,653 · 2025 $1,465
Food & beverage: $1,465
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $279 |
| Novo Nordisk Inc | 8 | $234 |
| Phathom Pharmaceuticals, Inc. | 3 | $149 |
| Aimmune Therapeutics, Inc. | 7 | $131 |
| SCPHARMACEUTICALS INC. | 1 | $125 |
| Ardelyx, Inc. | 4 | $107 |
| Lundbeck LLC | 4 | $102 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $77 |
| Lilly USA, LLC | 2 | $45 |
| ABBVIE INC. | 2 | $41 |
Products named: Ozempic, FARXIGA, VOQUEZNA, FUROSCIX, ZENPEP, IBSRELA, REXULTI, JARDIANCE.
Industry payments across TX — which companies pay providers there.
